參考文獻(xiàn)/References:
[1] 中華醫(yī)學(xué)會(huì)骨質(zhì)疏松和骨礦鹽疾病分會(huì).原發(fā)性骨質(zhì)疏松癥診療指南(2017)[J].中國(guó)骨質(zhì)疏松雜志,2019,25(3):281-309.
[2] 李塔娜.研究多種西藥聯(lián)合應(yīng)用的臨床不良反應(yīng)及應(yīng)對(duì)措施[J].世界最新醫(yī)學(xué)信息文摘,2019,19(50):221.
[3] 徐道明,許華寧,徐帥,等.原發(fā)性骨質(zhì)疏松癥慢性疼痛的康復(fù)治療進(jìn)展[J/OL].中國(guó)骨質(zhì)疏松雜志,2019[2020-02-
15].http://kns.cnki.net/kcms/detail/11.3701.R.20191017.0834.004.html.
[4] 唐中堯,李華,徐祖健.中藥治療骨質(zhì)疏松癥的用藥規(guī)律研究[J].中醫(yī)正骨,2019,31(1):20-22.
[5] 李建國(guó),謝興文,李寧,等.絕經(jīng)后骨質(zhì)疏松癥的中醫(yī)臟腑認(rèn)識(shí)及治療現(xiàn)狀[J].中國(guó)中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2019,25(3):410-412.
[6] 仇宋明,尹恒,王建偉.基于“脾腎相關(guān)”論治療骨質(zhì)疏松癥的研究進(jìn)展[J].中國(guó)骨質(zhì)疏松雜志,2019,25(12):1809-1811.
[7] 王國(guó)軍.“筋骨并重”理念在骨科疾病中的應(yīng)用[J].江蘇中醫(yī)藥,2019,51(11):41-44.
[8] 吳亞?wèn)|,魏杰,劉鐘,等.中藥經(jīng)皮給藥治療骨質(zhì)疏松癥的研究進(jìn)展[J].中醫(yī)正骨,2010,22(6):36-37.
[9] 朱曉龍.穴位貼敷療法的歷史沿革及現(xiàn)代研究[J].貴陽(yáng)中醫(yī)學(xué)院學(xué)報(bào),2010,32(2):1-3.
[10] 賀艷萍,肖小芹,鄧桂明,等.中藥穴位貼敷作用機(jī)理研究概況[J].中國(guó)中醫(yī)藥信息雜志,2017,24(3):134-136.
[11] 王朋林,鄭玲,張素梅,等.藥物透皮劑及促滲方法研究概況[J].動(dòng)物醫(yī)學(xué)進(jìn)展,2020,41(1):112-116.
[12] 李延紅,龔福太,石耀武,等.原發(fā)性骨質(zhì)疏松癥中西醫(yī)結(jié)合治療現(xiàn)狀及研究進(jìn)展[J].中國(guó)骨質(zhì)疏松雜志,2017,23(5):690-694.
[13] 史曉林,梁博程,李春雯.從“因虛致瘀”論原發(fā)性骨質(zhì)疏松癥病機(jī)[J].中國(guó)中西醫(yī)結(jié)合雜志,2019,39(1):111-114.
[14] 毛一凡,張佳鋒,陳文亮,等.從“虛瘀致毒”論骨痿骨折[J].中醫(yī)正骨,2019,31(2):44-45.
[15] 李孟飛,鄭永智,田永志,等.膏方及其在骨科疾病治療中的應(yīng)用[J].中醫(yī)正骨,2019,31(5):26-27.
[16] 王明熹,蔡慧顏.骨疏康顆粒聯(lián)合玉龍散外敷治療原發(fā)性骨質(zhì)疏松癥的臨床療效分析[J].海峽藥學(xué),2016,28(10):136-138.
[17] 闞麗君,李靜偉,潘定權(quán),等.改良五禽戲配合穴位敷貼治療骨質(zhì)疏松性椎體骨折的臨床療效觀察[J].中國(guó)骨質(zhì)疏松雜志,2014,20(8):924-926.
[18] 杜秀藩,黃弘軒,熊小龍,等.肉桂醛對(duì)去卵巢誘導(dǎo)的骨質(zhì)疏松大鼠模型骨密度和骨量的保護(hù)作用[J].中國(guó)骨質(zhì)疏松雜志,2019,25(9):1217-1220.
[19] 鄧宇,陳廖斌.淫羊藿苷通過(guò)激活Notch信號(hào)通路促進(jìn)骨髓間充質(zhì)干細(xì)胞向成骨細(xì)胞分化的實(shí)驗(yàn)研究[J].中醫(yī)學(xué)報(bào),2017,32(12):2393-2398.
[20] 袁真,閔珺,王愷,等.杜仲黃酮類3種藥物成分治療大鼠骨質(zhì)疏松的比較研究[J].中國(guó)骨質(zhì)疏松雜志,2018,24(2):244-248.
[21] 陳勇,劉穎.針刺加穴位貼敷治療原發(fā)性骨質(zhì)疏松癥臨床觀察[J].上海針灸雜志,2020,39(2):127-130.
[22] 林曉生,王海燕,肖慶華,等.天癸散敷臍干預(yù)圍絕經(jīng)期婦女骨量減少的臨床療效觀察[J].世界中西醫(yī)結(jié)合雜志,2017,12(1):70-73.
[23] 翁錢瑛,陳紅,邵日智.耳穴貼壓聯(lián)合穴位敷貼治療絕經(jīng)后骨質(zhì)疏松癥臨床觀察[J].新中醫(yī),2016,48(5):141-142.
[24] 馬俊義,施振宇,史曉林.穴位貼敷療法對(duì)絕經(jīng)后骨質(zhì)疏松患者血清OPG、RANKL和髖部骨密度的影響[J].中國(guó)骨質(zhì)疏松雜志,2017,23(7):921-925.
[25] 何康宏,梁博程,李旭云,等.中藥穴位敷貼治療絕經(jīng)后骨質(zhì)疏松癥[J].長(zhǎng)春中醫(yī)藥大學(xué)學(xué)報(bào),2015,31(6):1240-1242.
[26] 熊凍,李代英,龔正壽,等.中藥炎黃散聯(lián)合依降鈣素治療骨質(zhì)疏松性疼痛的療效觀察[J].醫(yī)藥前沿,2019,9(9):211-212.
[27] 張冬梅,張鵬,王崢,等.子午流注納支法穴位貼敷在老年性骨質(zhì)疏松患者中的應(yīng)用[J].中國(guó)老年學(xué)雜志,2019,39(17):4253-4256.
[28] 韓怡菊,杜敏.子午流注納支法穴位敷貼治療肝腎不足證老年性骨質(zhì)疏松癥療效觀察[J].中國(guó)臨床研究,2019,32(1):103-106.
相似文獻(xiàn)/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補(bǔ)腎活血方對(duì)去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補(bǔ)腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):7.
[3]李學(xué)朋,朱立國(guó).骨疏康膠囊對(duì)去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):12.
[4]陳冠軍,陳揚(yáng),莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[5]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(05):27.
[6]黃建華,黃建武,李慧輝,等.加味左歸丸對(duì)絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(05):19.
[7]項(xiàng)旻,楊虹,林愛(ài)菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(05):20.
[8]史曉林,李春雯,張志強(qiáng).弱陽(yáng)離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時(shí)間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(05):5.
[9]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機(jī)制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(05):21.
[10]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(05):16.
[11]汪青,黃昊強(qiáng),陳勇,等.二仙湯在絕經(jīng)后骨質(zhì)疏松癥腎陽(yáng)虛證治療中的應(yīng)用價(jià)值及作用機(jī)制研究[J].中醫(yī)正骨,2022,34(03):8.
WANG Qing,HUANG Haoqiang,CHEN Yong,et al.Applied values and mechanism of action of oral application of Erxian Tang(二仙湯)in treatment of postmenopausal osteoporosis with syndrome of kidney-yang deficiency:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(05):8.